Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16661)	2/24/2004 6:48:38 PM
From: Robert S.	Read Replies (1) \| Respond to of 17367

Interesting........................ As usual the small retail investor in biotechnology has born the brunt of the waiting game. Stock ownership during years and year of losses, then when the going gets good, the institutions move in a take ownership and the little guy exits and misses the run. Fortunately for everyone, we have you to explain what is really going on. As far as the acne trial goes, it looks like a no brainer. Indeed. I am much more interested in the bpi trial and platform progression. As you have been lo these many years. As far as anti-cd11a goes I think it "almost" funny that xoma finally has something to brag about and the judge (DNA) has issued a gag order and xoma can only beat around the bush so to speak. You're sure about this? One final-news is always coming and there is lots to come. No doubt, it will all be good news. Cheers!